Zhongke Meiling Cryogenics Co (BJSE:920992) EBIT: ¥17.6 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920992 Zhongke Meiling Cryogenics Co Ltd BJSE:920992
62 GF Score
Price ¥11.78
GF Value ¥13.38
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Zhongke Meiling Cryogenics Co EBIT?

Zhongke Meiling Cryogenics Co BJSE:920992 62 EBIT is ¥17.6 Mil as of Jun. 2026. GuruFocus rates BJSE:920992 with a GF Score™ of 62/100 and a GF Value™ of ¥13.38 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Zhongke Meiling Cryogenics Co's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2026 was ¥3.8 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2026 was ¥17.6 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Zhongke Meiling Cryogenics Co's annualized ROC % for the quarter that ended in Jun. 2026 was 5.74%. Zhongke Meiling Cryogenics Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 16.16%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Zhongke Meiling Cryogenics Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 3.15%.


Zhongke Meiling Cryogenics Co  (BJSE:920992) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Zhongke Meiling Cryogenics Co's annualized ROC % for the quarter that ended in Jun. 2026 is calculated as:

ROC % (Q: Jun. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2026 ) + Invested Capital (Q: Jun. 2026 ))/ count )
=8.38 * ( 1 - 0.61% )/( (149.08 + 140.919)/ 2 )
=8.328882/144.9995
=5.74 %

where

Invested Capital(Q: Jun. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=752.839 - 104.982 - ( 565.424 - max(0, 120.138 - 627.076+565.424))
=140.919

Note: The Operating Income data used here is four times the quarterly (Jun. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Zhongke Meiling Cryogenics Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2026  Q: Jun. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=15.196/( ( (95.085 + max(-72.854, 0)) + (92.963 + max(-57.482, 0)) )/ 2 )
=15.196/( ( 95.085 + 92.963 )/ 2 )
=15.196/94.024
=16.16 %

where Working Capital is:

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(9.316 + 38.169 + 2.1400000000001) - (104.094 + 0 + 18.385)
=-72.854

Working Capital(Q: Jun. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(13.818 + 41.04 + 4.4200000000001) - (104.982 + 0 + 11.778)
=-57.482

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Zhongke Meiling Cryogenics Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2026 )
=17.591/558.784
=3.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhongke Meiling Cryogenics Co EBIT Related Terms


Zhongke Meiling Cryogenics Co EBIT Historical Data

* Premium members only.

The historical data trend for Zhongke Meiling Cryogenics Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhongke Meiling Cryogenics Co EBIT Chart

Zhongke Meiling Cryogenics Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 74.98 58.31 17.89 18.15 19.09

Zhongke Meiling Cryogenics Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.68 2.00 6.18 5.62 3.80

BJSE:920992 vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, Zhongke Meiling Cryogenics Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhongke Meiling Cryogenics Co EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zhongke Meiling Cryogenics Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Zhongke Meiling Cryogenics Co's EV-to-EBIT falls into.


BJSE:920992
62GF Score
Zhongke Meiling Cryogenics Co Ltd BJSE:920992
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhongke Meiling Cryogenics Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥17.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ¥17.6 Mil mean?
Zhongke Meiling Cryogenics Co (BJSE:920992) has a EBIT of ¥17.6 Mil as of Jun. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Zhongke Meiling Cryogenics Co.
Is Zhongke Meiling Cryogenics Co's EBIT too high?
Zhongke Meiling Cryogenics Co's current EBIT is ¥17.6 Mil. Overall, Zhongke Meiling Cryogenics Co has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhongke Meiling Cryogenics Co's EBIT compare to ABT and SYK?
Zhongke Meiling Cryogenics Co's EBIT of ¥17.6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Zhongke Meiling Cryogenics Co. Zhongke Meiling Cryogenics Co's current EBIT is ¥17.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhongke Meiling Cryogenics Co stock overvalued right now?
Based on GuruFocus' analysis, Zhongke Meiling Cryogenics Co (BJSE:920992) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥13.38, compared to a current price of ¥11.78 — trading 12% below its estimated fair value. The current EBIT is ¥17.6 Mil. Zhongke Meiling Cryogenics Co's overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Zhongke Meiling Cryogenics Co (BJSE:920992), the current EBIT is ¥17.6 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhongke Meiling Cryogenics Co (BJSE:920992) Overvalued in 2026?

Based on GuruFocus' analysis, Zhongke Meiling Cryogenics Co stock appears to be undervalued. The current stock price of ¥11.78 is trading 12% below its estimated GF Value™ of ¥13.38. GuruFocus considers Zhongke Meiling Cryogenics Co to be Modestly Undervalued.

Key valuation signals for BJSE:920992:

  • EBIT: ¥17.6 Mil
  • GF Value™: ¥13.38 vs. price of ¥11.78 (12% below fair value)
  • GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the BJSE:920992 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhongke Meiling Cryogenics Co Business Description

Address No. 1862 Zishi Road, Economic and Technological Development Zone, Anhui Province, Hefei City, CHN, 230601
Zhongke Meiling Cryogenics Co Ltd engages in research and development, production, and sales of biomedical cryogenic storage equipment. The company's main products include a lab / medical refrigerator and freezer, ultra-low temperature freezer, blood bank refrigerator, inventory rack/box, professional cold room, and bio-bank management.
62GF Score

Get the complete analysis for BJSE:920992

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥11.78
Price
¥13.38
GF Value